MedTrace Logo

The PIP Study - Pre- IVF Immune Profiling Study

NCT03660735 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2018-10-29

No results posted yet for this study

Summary

Many IVF clinics offer testing for immune cells in the blood and endometrium as it has been suggested that abnormal levels of these cells can affect fertility or the chance of an IVF cycle working. However, routinely offering these tests remains highly controversial as the scientific evidence behind the tests is not of a high quality. The PIP Study aims to find out how a woman's blood and endometrial immune cells affect the likelihood of an IVF cycle working and whether or not they are different in women with subfertility and implantation failure. This feasibility study aims to find out if it is possible to enrol enough women into the research study. If this is successful, the investigators will then go on to recruit a larger group of women into the main PIP study to enable them to investigate the impact of immune profiling on IVF success in more detail.

Conditions

  • Sub-fertility
  • Recurrent Implantation Failure

Sponsors & Collaborators

  • Finox Biotech

    collaborator UNKNOWN

  • University of Oxford

    lead OTHER

Principal Investigators

  • Ingrid Granne, DPhil MA MBBS MRCOG · University of Oxford

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-26
Primary Completion
2021-08-01
Completion
2021-08-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03660735 on ClinicalTrials.gov